Skip to main content
. 2018 Aug 21;97(35):e12193. doi: 10.1097/MD.0000000000012193

Figure 2.

Figure 2

The disease-free survival of patients in Single Surgery, Surgery + CRT, and Surgery + CRT + rAd-p53 groups. Compared with Single Surgery, Surgery + CRT groups, the disease-free survival rates of Surgery + CRT + rAd-p53 groups were significantly enhanced (P < .05). CRT = chemoradiotherapy, rAd-p53 = recombinant adenovirus-p53.